Matthew Reynolds to Atrial Flutter
This is a "connection" page, showing publications Matthew Reynolds has written about Atrial Flutter.
Connection Strength
0.637
-
Reynolds MR, Lin J, Jhaveri M, Mozaffari E, Plich A. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. Am J Ther. 2014 Nov-Dec; 21(6):500-8.
Score: 0.449
-
Kleinman NL, Rohrbacker NJ, White SA, March JL, Reynolds MR. Economic impact to employers of treatment options for cardiac arrhythmias in the US health system. J Occup Environ Med. 2011 Apr; 53(4):405-14.
Score: 0.088
-
Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009 Sep 01; 104(5):671-7.
Score: 0.079
-
Kotowycz MA, Filion KB, Joza J, Dube D, Reynolds MR, Pilote L, Eisenberg MJ, Essebag V. In-hospital management of atrial fibrillation: the CHADS2 score predicts increased cost. Can J Cardiol. 2011 Jul-Aug; 27(4):506-13.
Score: 0.022